Related Experiment Video
Updated: Jun 20, 2026
07:20
Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
[Repetitive peripheral magnetic stimulation. Treatment option for spasticity?]
1Neurologisches Rehabilitationszentrum für Kinder und Jugendliche, HELIOS-Klinik Hohenstücken, Brahmsstrasse 38, Brandenburg. helgrit.marz-loose@helios-kliniken.de
Der Nervenarzt
|September 19, 2009
Summary
Repetitive peripheral magnetic stimulation (RPMS) effectively reduced spasticity in children with talipes equinus for up to one week. Further evidence-based studies are needed to confirm RPMS as a viable treatment option.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Biomedical Engineering
Background:
- Spastic talipes equinus affects children and adolescents, impacting mobility and quality of life.
- Current treatments for spasticity have limitations, necessitating exploration of novel therapeutic approaches.
Purpose of the Study:
- To evaluate the efficacy of repetitive peripheral magnetic stimulation (RPMS) in managing spastic talipes equinus.
- To assess the impact of RPMS on spasticity and functional capabilities.
- To determine the duration of therapeutic effect following a single RPMS session.
Main Methods:
- An open-label study involving 53 pediatric patients with spastic talipes equinus.
- RPMS applied over the first sacral radix (20 Hz, 1.2x motor threshold, 10 series x 10s).
- Clinical and electrophysiological assessments (F-wave, H-reflex, ASR tendon reflex) were conducted.
Main Results:
- RPMS significantly decreased muscle tonus in spastic talipes equinus.
- The observed reduction in spasticity persisted for one week post-treatment.
- No significant alterations were detected in electrophysiological parameters.
Conclusions:
- RPMS demonstrates potential as an effective non-invasive treatment for spasticity.
- Further rigorous, evidence-based research is warranted to validate these findings.
- RPMS may offer a promising therapeutic avenue for pediatric spasticity management.
